Cardiology · Mitochondrial DNA m.3243A>G Variant-Associated Disease

The Clinical Spectrum: MIDD, MELAS, and Overlap Symptoms

At a Glance

The m.3243A>G variant can affect people differently: hearing loss and cardiomyopathy may occur without diabetes or stroke. MIDD describes diabetes with hearing loss, while MELAS requires stroke-like episodes, and sudden neurologic symptoms need emergency care.

The m.3243A>G variant is often described as a “clinical chameleon” because it looks different in every person it affects ^[1]. While doctors use specific names like MIDD or MELAS to group symptoms together, many people do not fit neatly into one box. Instead, they may have an “overlap” or “non-syndromic” phenotype, where they experience some symptoms—like hearing loss and heart issues—without others—like diabetes or strokes ^[2].

EMERGENCY ALERT: Stroke-Like Episodes

If you experience sudden neurologic symptoms, call emergency services (911) immediately. Do not wait to contact your mitochondrial care team, and do not attempt to self-treat with home supplements like L-arginine. Go to the nearest emergency department and inform them of your mitochondrial diagnosis.

Red Flag Symptoms include:

Sudden weakness or numbness on one side of the body
Trouble speaking or understanding speech
New, sudden vision loss or changes
Severe or highly unusual headaches
Sudden confusion, altered mental state, or seizure

These could be signs of a MELAS stroke-like episode, which can initially be indistinguishable from a standard ischemic stroke and requires immediate emergency evaluation.

MIDD: Maternally Inherited Diabetes and Deafness

MIDD conventionally refers to the phenotype involving diabetes and hearing loss ^[3].

Diabetes: This usually develops in adulthood, often in a person’s 30s or 40s ^[4]. Unlike typical Type 2 diabetes, people with MIDD are often lean (low BMI) ^[5].
Deafness: This refers to sensorineural hearing loss, which is often progressive and affects both ears ^[6].
Maternal History: A history of these same symptoms on the mother’s side is supportive, but it is not required for the diagnosis ^[5].

Isolated hearing loss or isolated diabetes does not mean that the other feature will inevitably develop. In one cohort study, only 38% of people with the variant had both simultaneously ^[7]. You may have hearing loss for years without diabetes ever appearing ^[8].

MELAS: A Neurological Syndrome

MELAS stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes. This is a severe presentation that involves the brain ^[9].

Stroke-like Episodes: These are the hallmark of MELAS. They may look like a typical stroke (weakness on one side, vision loss, or confusion), but they are not caused by a blocked artery ^[10]. Instead, they are metabolic crises where the brain cells cannot get enough energy to function ^[11].
Other Symptoms: MELAS often includes seizures, severe migraines, and a buildup of lactic acid in the blood ^[12]^[13].

Note: Having the m.3243A>G variant does not mean you have MELAS. A MELAS diagnosis requires these specific neurological events. Many people carry the variant for their entire lives without ever having a stroke-like episode, and the future risk of a stroke-like episode cannot be inferred from the variant alone ^[14].

The Overlap: Hearing Loss and Cardiomyopathy

Many patients fall into a “non-MELAS” or “other” category ^[1]. If you have hearing loss and cardiomyopathy (heart muscle disease) but do not have diabetes or strokes, you have a recognized multisystem phenotype ^[15].

Cardiac Involvement: Heart muscle thickening or weakening can occur independently of other major syndromes ^[16]. It is a significant feature of the variant’s spectrum, affecting about 23% of people in some groups ^[4].
The “Spectrum” Concept: Doctors are increasingly using the term MELAS-spectrum syndrome to describe people who have various symptoms of the variant but have not had a stroke-like episode, though terminology varies among specialists ^[17].

Because of this overlap, your medical team will monitor you for the “full spectrum” of symptoms. Regular screenings for blood sugar (diabetes) and kidney function are common parts of long-term care ^[18]^[19]. This proactive approach ensures that any new symptoms are caught and managed as early as possible.

Common questions in this guide

What is the difference between MIDD and MELAS?

MIDD describes a pattern of diabetes, usually developing in adulthood, together with progressive sensorineural hearing loss. MELAS is a neurological presentation defined by stroke-like episodes and may also involve seizures, severe migraines, and lactic acidosis. Carrying m.3243A>G does not automatically mean a person has either syndrome.

Can I have hearing loss and cardiomyopathy without diabetes or a stroke?

Yes. Hearing loss with cardiomyopathy and without diabetes or stroke is a recognized overlap or non-syndromic presentation of the m.3243A>G spectrum. Symptoms of this variant vary from person to person.

Does carrying m.3243A>G mean I will develop MELAS?

No. Many people with the variant never have a stroke-like episode, and the variant alone cannot predict whether one will occur. Sudden weakness, speech trouble, vision changes, confusion, a seizure, or an unusual severe headache should be treated as an emergency.

Which symptoms require emergency care for a possible MELAS episode?

Call emergency services immediately for sudden one-sided weakness or numbness, trouble speaking or understanding speech, new vision loss, a severe or unusual headache, sudden confusion, or a seizure. These symptoms can resemble a typical blocked-artery stroke, so do not wait to contact your mitochondrial team or try to treat yourself at home.

Should I be screened for diabetes and kidney problems if my blood sugar is normal?

Regular blood sugar testing and kidney function checks are commonly part of long-term monitoring for people with m.3243A>G-related disease, even when current blood sugar is normal. Ask your mitochondrial care team how often you need testing.

How often should my heart and hearing be checked?

The schedule depends on your symptoms, test results, and care team because cardiomyopathy and hearing loss can change over time. Your clinicians can set a personalized plan for heart assessments and hearing tests.

Is a maternal family history required for MIDD?

No. Diabetes and hearing loss in the maternal family can support the diagnosis, but their absence does not rule out an m.3243A>G-related condition. Family patterns can vary because symptoms are not the same in every person.

Get notified when new evidence is published on Mitochondrial DNA-related cardiomyopathy and hearing loss.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (19)

1
Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variant.
de Laat P, Rodenburg RR, Roeleveld N, et al.
Journal of medical genetics 2021; (58(1)):48-55 doi:10.1136/jmedgenet-2019-106800.
PMID: 32439810
2
Phenotypic Heterogeneity in 5 Family Members with the Mitochondrial Variant m.3243A>G.
Finsterer J, Laccone F
The American journal of case reports 2020; (21()):e927938 doi:10.12659/AJCR.927938.
PMID: 33237887
3
Management of mitochondrial diabetes in the era of novel therapies.
Yeung RO, Al Jundi M, Gubbi S, et al.
Journal of diabetes and its complications 2021; (35(1)):107584 doi:10.1016/j.jdiacomp.2020.107584.
PMID: 32331977
4
The Mutations and Clinical Variability in Maternally Inherited Diabetes and Deafness: An Analysis of 161 Patients.
Yang M, Xu L, Xu C, et al.
Frontiers in endocrinology 2021; (12()):728043 doi:10.3389/fendo.2021.728043.
PMID: 34899594
5
Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach.
Oppenheimer KR, Himelhoch NT, McCullough ME, et al.
The Journal of clinical endocrinology and metabolism 2026; (111(4)):1175-1186 doi:10.1210/clinem/dgaf698.
PMID: 41472381
6
Clinical characteristics and hearing impairment in carriers of the m.3243 A > G variant.
Uehara N, Fujita T, Uehara K, et al.
Journal of human genetics 2026; (71(3)):145-149 doi:10.1038/s10038-025-01412-3.
PMID: 41131326
7
Screening for Maternally Inherited Diabetes and Deafness in Large Cohorts of Hearing Impaired and Diabetic Patients.
Varga L, Borecka S, Skopkova M, et al.
Ear and hearing 2026; (47(3)):863-876 doi:10.1097/AUD.0000000000001780.
PMID: 41664274
8
Case report: mitochondrial diabetes mellitus in a Chinese family due to m.3243A>G.
Bai W, Zhang Q, Fan Y, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(8)):777-781 doi:10.1515/jpem-2023-0016.
PMID: 37459161
9
When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis?
Lorenzoni PJ, Werneck LC, Kay CS, et al.
Arquivos de neuro-psiquiatria 2015; (73(11)):959-67.
PMID: 26517220
10
Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS.
Tetsuka S, Ogawa T, Hashimoto R, Kato H
Metabolic brain disease 2021; (36(8)):2181-2193 doi:10.1007/s11011-021-00772-x.
PMID: 34118021
11
Stroke-like episodes in adult mitochondrial disease.
Ng YS, Gorman GS
Handbook of clinical neurology 2023; (194()):65-78 doi:10.1016/B978-0-12-821751-1.00005-1.
PMID: 36813321
12
Headache in mitochondrial diseases: From migraine to stroke-like episodes.
Azzimonti M, Padelli S, Ronchi D, et al.
Headache 2026; doi:10.1111/head.70180.
PMID: 42452951
13
Mitochondrial mutation status, symptom prevalence, and neuroimaging characteristics in MELAS: a systematic review and meta analysis.
Li Y, Han S, Huang D, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42271506
14
Outcomes misaligned in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): implications for trial design.
Stefanetti RJ, Charman SJ, Newman J, et al.
Brain communications 2025; (7(5)):fcaf342 doi:10.1093/braincomms/fcaf342.
PMID: 41048545
15
The non-syndromic clinical spectrums of mtDNA 3243A>G mutation.
Shen X, Du A
Neurosciences (Riyadh, Saudi Arabia) 2021; (26(2)):128-133 doi:10.17712/nsj.2021.2.20200145.
PMID: 33814365
16
Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
Niedermayr K, Pölzl G, Scholl-Bürgi S, et al.
Congenital heart disease 2018; (13(5)):671-677 doi:10.1111/chd.12634.
PMID: 30133155
17
Progressive encephalopathy in m.3243A > G/MT-TL1 mutation carriers: a quantitative EEG analysis.
Scarabello A, Mason F, Ferri L, et al.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2025; (177()):2110822 doi:10.1016/j.clinph.2025.2110822.
PMID: 40633301
18
Impediments to Heart Transplantation in Adults With MELASMT-TL1:m.3243A>G Cardiomyopathy.
Di Toro A, Urtis M, Narula N, et al.
Journal of the American College of Cardiology 2022; (80(15)):1431-1443 doi:10.1016/j.jacc.2022.04.067.
PMID: 36202533
19
Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea.
Rho EH, Baek SI, Lee H, et al.
Diabetes & metabolism journal 2024; (48(3)):482-486 doi:10.4093/dmj.2023.0078.
PMID: 38311059

This page is for informational purposes only and does not constitute medical advice. Discuss your m.3243A>G-related symptoms and monitoring plan with your mitochondrial care team, and seek emergency care for sudden neurologic symptoms.

Guide Contents